We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

10 hedge funds and large institutions have $1.25M invested in TuHURA Biosciences in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

43% more funds holding

Funds holding: 7 → 10 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

4% less capital invested

Capital invested by funds: $1.3M → $1.25M (-$51.1K)

Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LTFS
Ladenburg Thalmann Financial Services
Florida
+$43.8K
2
VF
Virtu Financial
New York
+$43.8K
3
Citadel Advisors
Citadel Advisors
Florida
+$21.9K
4
CGA
Crescent Grove Advisors
Illinois
+$21.9K
5
TSS
Two Sigma Securities
New York
+$21.9K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$22K
2
WOC
West Oak Capital
California
-$98

HURA Hedge Fund Activity: Q1 2018 in Review

10 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2018, worth a combined $1.25M — down 3.9% from $1.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HURA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Ladenburg Thalmann Financial Services, opening a new position worth an estimated $43.8K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $22K sold.

  • 10 institutional investors held TuHURA Biosciences (HURA) as of Q1 2018, up from 7 in Q4 2017.
  • Funds reported $1.25M of TuHURA Biosciences stock for Q1 2018, down 3.9% quarter-over-quarter.
  • 4 funds opened new TuHURA Biosciences positions in Q1 2018 and 1 closed out, a net change of +3 holders.
  • The largest TuHURA Biosciences buyer in Q1 2018 was Ladenburg Thalmann Financial Services, an estimated $43.8K added.
  • The largest TuHURA Biosciences seller in Q1 2018 was Two Sigma Investments, an estimated $22K sold.

Based on aggregated 13F filings for Q1 2018.